Quebec says it will start using human papillomavirus tests as its primary screening tool for cervical cancer, replacing the Pap smear. The Health Department says the province will systematically offer HPV testing for cervical cancer screening to all women aged 25 to 65, every five years. Earlier this year, the Institut national d’excellence en santé et en services sociaux reported that the HPV test is more sensitive than a Pap smear and could allow patients to collect their own test samples.
Category:
Published on: 1 Jun 2022
A recent study by researchers at McGill University has identified polycystic ovary syndrome (PCOS) as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy. The condition, known to lead to multiple reproductive complications, including infertility, affects 1 in 10 women of childbearing age.
PCOS was already known for its association to other adverse perinatal conditions, such as insulin resistance. However, there remains significant gaps in understanding the correlation between the syndrome and neonatal complications.
Category:
Published on: 6 Oct 2020
A native Montrealer, Dr. Gabrielle Cassir completed her medical school and residency training at Université de Montreal. During her time as a medical student, she was also able to experience the American health care system, spending two months at Jackson Memorial Hospital in Miami. She completed two-years of subspecialty training in Maternal-Fetal Medicine at Mount Sinai Hospital in Toronto, before returning to Montreal where she recently became a staff physician in the Obstetrics and Gynecology division at St.
Category:
Published on: 1 Mar 2019
Each year, the Department of Obstetrics & Gynecology at McGill organize a symposium to review new studies and practices in order to help practicing gynecologists, family physicians, residents, fellows and allied health professionals with interest in Women’s Health. (Website)
Category:
Published on: 13 Sep 2016
